Amarin's NCE Update
If you have been following my instablog, I told you NCE status update would likely be today (not this Friday), and it was.
I am learning that FDA is likely to announce the ruling around or in direct time relation to Anchor vote in December. If so, this is a favorable indication for Amarin in my opinion. A 'no' could be handed down at any time. I have never been a subscriber that NCE is tied to Anchor, but from a pure manpower FDA resource standpoint, that case is getting more convincing and there have been some attorneys close to the matter suggesting this. It also alludes to expected YES vote for Anchor approval, should be an easy go ahead for Anchor and we should get that nod in October from FDA panel. $20+ stock selling for singles here folks...
Stay tuned.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.